Characterizing Attitudes Toward Maternal RSV Vaccines Among Pregnant and Lactating Persons in Kenya: Key Considerations for Demand Generation Efforts for Vaccine Acceptance-Reference-Cited by-同舟云学术

Characterizing Attitudes Toward Maternal RSV Vaccines Among Pregnant and Lactating Persons in Kenya: Key Considerations for Demand Generation Efforts for Vaccine Acceptance

Published:2023-11-07 Issue:12 Volume:12 Page:638-641
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Limaye Rupali J¹²³⁴^ORCID,Sauer Molly¹²,Njogu Rosemary⁵,Singh Prachi²^ORCID,Fesshaye Berhaun²,Karron Ruth A¹

Affiliation:

1. Department of International Health, Johns Hopkins University, Bloomberg School of Public Health , Baltimore, Maryland , USA

2. Department of International Health, International Vaccine Access Center, Johns Hopkins University, Bloomberg School of Public Health , Baltimore, Maryland , USA

3. Department of Health, Behavior & Society, Johns Hopkins University, Bloomberg School of Public Health , Baltimore, Maryland , USA

4. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health , Baltimore, Maryland , USA

5. Department of International Health, Jhpiego , Nairobi , Kenya

Abstract

Abstract This study examined attitudes toward maternal RSV vaccines among pregnant and lactating persons in Kenya. First pregnancy was associated with higher vaccine hesitancy among pregnant and lactating people, and social norms were associated with higher vaccine hesitancy among lactating people. Understanding maternal RSV attitudes is critical for vaccine acceptance.

Funder

Bill and Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

https://academic.oup.com/jpids/advance-article-pdf/doi/10.1093/jpids/piad098/53000716/piad098.pdf

Reference12 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet (London, England),2022

2. Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children;Viguria;Hum Vaccin Immunother,2021

3. Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010–2018;Nyawanda;BMC Med,2023

4. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants;Kampmann;N Engl J Med,2023

5. Maternal immunisation: collaborating with mother nature;Marchant;Lancet Infect Dis,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland;Immunity, Inflammation and Disease;2024-04